What is Yonghe Medical Group Co., Ltd.'s (2279.HK) StockRank?

MoatMap's StockRank for Yonghe Medical Group Co., Ltd. (2279.HK) is 99/100, with a Strong Buy signal. This is a composite score combining Quality (68), Value (82), and Momentum (59) factor ranks across MoatMap's 19,000+ stock universe.

Does Yonghe Medical Group Co., Ltd. have an economic moat?

Yonghe Medical Group Co., Ltd. (2279.HK) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Yonghe Medical Group Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Yonghe Medical Group Co., Ltd. (2279.HK) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Yonghe Medical Group Co., Ltd. in?

Yonghe Medical Group Co., Ltd. (2279.HK) operates in the Healthcare sector, specifically the Medical Care Facilities industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

2279.HK

STRONG BUYREMOVE

Yonghe Medical Group Co., Ltd. · Healthcare · China · $132M · Avg Vol: $70K/d

StockRank

P/E (TTM)

12.1x

ROE

9.8%

D/E

0.6x

Dividend %

3.7%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Yonghe Medical Group operates hair transplant clinics in China, representing a highly discretionary consumer service facing severe domestic economic headwinds.

COMPANY DESCRIPTION

Yonghe Medical Group Co., Ltd. is the largest hair transplant and hair care service provider in China, operating a nationwide network of specialized clinics. The company offers comprehensive hair loss solutions, including surgical transplants and medical hair care under the 'Svenson' brand. Its dominant market share, standardized clinical protocols, and extensive brand recognition form a formidable competitive barrier.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	180M	227M	230M	231M	8.6%
EPS	-0.02	-0.14	-0.06	0.02	—
Shares	527M	527M	526M	525M	-0.3%
Debt	132M	140M	85M	62M	-22.4%
Equity	202M	120M	91M	101M	-20.8%
Op CF	-14M	-2M	29M	63M	116.8%
Inv CF	-83M	31M	-7M	-9M	—
Fin CF	-43M	-24M	-37M	-28M	—

PRICE (1M)+0.5%

SMA 50SMA 200

$0.27

RSI (14)

38.8

52W High

$0.44

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

11.1%76.5

ROE

9.8%71.5

GP/Assets

81.3%95.5

Op. Margin

8.0%61.4

FCF/Assets

27.5%97.5

Piotroski

—83.5

Int. Cover

5.6x55.7

D/E Ratio

0.62x26.9

Current Ratio

1.55x26.2

Value

P/E (TTM)

12.1x82.7

EV/EBITDA

2.6x60.5

P/FCF

17.3x98.1

P/B

1.0x79.4

P/S

0.5x93.0

Div Yield

3.7%80.2

Momentum

52W High %

61%42.2

RS 6M

33%91.0

SMA 50/200

1.03x68.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—56.0

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$132M

P/E (Forward)

7.9x

Gross Margin

66.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 2279.HK are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
2279.HK	Yonghe Medical Group Co., Ltd.(you)	$132M	99	STRONG BUY
2219.HK	Chaoju Eye Care Holdings Limited	$228M	100	STRONG BUY
2651.HK	Wuhan Dazhong Dental Medical Co., Ltd.	$81M	97	STRONG BUY
1515.HK	China Resources Medical Holdings Company Limited	$415M	89	STRONG BUY
2273.HK	Gushengtang Holdings Limited	$772M	96	STRONG BUY
2581.HK	BenQ BM Holding Cayman Corp.	$125M	58	HOLD
2373.HK	Beauty Farm Medical and Health Industry Inc.	$621M	88	STRONG BUY
2677.HK	Distinct Healthcare Hldg Ltd	$179M	36	HOLD
2508.HK	Saint Bella Group Limited	$314M	43	HOLD
6078.HK	Hygeia Healthcare Holdings Co., Limited	$752M	61	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Yonghe Medical Group Co., Ltd. (2279.HK) — Stock Score Summary

Yonghe Medical Group Co., Ltd. (2279.HK) has a MoatMap StockRank of 99/100 based on Quality (68/100), Value (82/100), and Momentum (59/100) factor scores. The current signal is STRONG BUY. Yonghe Medical Group operates hair transplant clinics in China, representing a highly discretionary consumer service facing severe domestic economic headwinds.

Key Financial Metrics

Price	$0.27
Market Cap	$132M
P/E (TTM)	12.12
P/E (Forward)	7.86
Price/Book	0.98
Return on Equity	9.8%
Return on Invested Capital	11.1%
Debt/Equity	61.56
Gross Margin	66.0%
Operating Margin	8.0%
Revenue Growth	4.7%
Dividend Yield	3.7%
Free Cash Flow	$8M

Yonghe Medical Group Co., Ltd. operates in the Medical Care Facilities industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Yonghe Medical Group Co., Ltd.’s (2279.HK) StockRank?: MoatMap’s StockRank for Yonghe Medical Group Co., Ltd. (2279.HK) is 99/100, with a Strong Buy signal. It is a composite of Quality (68), Value (82), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Yonghe Medical Group Co., Ltd. have an economic moat?: Yonghe Medical Group Co., Ltd. (2279.HK) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Yonghe Medical Group Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Yonghe Medical Group Co., Ltd. (2279.HK) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Yonghe Medical Group Co., Ltd. in?: Yonghe Medical Group Co., Ltd. (2279.HK) operates in the Healthcare sector, specifically the Medical Care Facilities industry (China).